In the current analyses, we characterized the immunohistochemical expression of PD-1, PD-L1, LAG-3 and TIM-3 in tumor cells and TILs in a cohort of untreated DLBCL patients and correlated their expression with pathologic and clinical features. Here, CD274 is linked to neoplasm.